Immix Biopharma, Inc.'s total assets for Q were $28.84M, a decrease of -16.05% from the previous quarter. IMMX total liabilities were $4.94M for the fiscal quarter, a -26.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.